North America Basal Cell Skin Cancer Treatment Industry Outlook 2034: Drivers, Challenges & Key Players
The United States is the largest national market for basal cell skin cancer treatment in North America, driven by the high incidence of basal cell carcinoma (BCC), the most common form of skin cancer, along with an aging population, high cumulative UV exposure, and widespread skin cancer screening. Surgical options such as Mohs micrographic surgery, excision, and curettage remain the standard...
0 Commentarios 0 Acciones 9 Views 0 Vista previa